Coverage
-
May 10, 2017
A New York federal judge on Wednesday awarded investment banking advisory firm Peter J. Solomon Co. LP nearly $5 million in fees and interest from the $200 million sale of the British biotech formerly known as Spirogen Ltd. to an to an AstraZeneca PLC subsidiary.
2 other articles on this case.
View all »